These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Histologic components of benign prostatic hypertrophy (bph) in relation to the androgen-estrogen status (author's transl)]. Seppelt U; Buhl K; Drews M Urologe A; 1978 Mar; 17(2):117-9. PubMed ID: 76360 [TBL] [Abstract][Full Text] [Related]
46. Benign prostatic hyperplasia. The scope of the problem. Grayhack JT Cancer; 1992 Jul; 70(1 Suppl):275-9. PubMed ID: 1376196 [TBL] [Abstract][Full Text] [Related]
47. Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study. Frea B; Annoscia S; Stanta G; Lozzi C; Carmignani G Urol Res; 1987; 15(5):311-4. PubMed ID: 2446412 [TBL] [Abstract][Full Text] [Related]
48. On call. As a retired physician, I particularly appreciate "Harvard Men's Health Watch" since it's an easy way for me to learn about new developments in medicine. As a 78-year-old man with an enlarged prostate, I'm particularly interested in your fine articles about BPH. But if memory serves me right, we called the condition "benign prostatic hypertrophy" when I was in practice, but now you call it "benign prostatic hyperplasia." What's the difference? Simon HB Harv Mens Health Watch; 2012 May; 16(10):8. PubMed ID: 22670285 [No Abstract] [Full Text] [Related]
49. Endocrine treatment of benign prostatic hypertrophy: current concepts. Matzkin H; Braf Z Urology; 1991 Jan; 37(1):1-16. PubMed ID: 1702565 [TBL] [Abstract][Full Text] [Related]